[Key words: glutamate release, ischemia, Na/K-A TPase, Na-excita tory amino acid cotransporter, A TP, hypoglycemia, neuron] A large body of evidence now supports the concept that increased extracellular concentrations of excitatory amino acids ([EAAs] ,) can contribute to the neuronal death seen in many CNS diseases, including ischemia, hypoglycemia, and epilepsy (Rothman and Olney, 1986; Choi, 1988) . Although numerous studies have confirmed that excessive activation of receptors by EAAs can kill neurons (Choi, 1988) and that [EAAs] , increase during CNS insults, little is known about the mechanism(s) producing these increases in systems more complex than syn-aptosomes. The relative importance of increased release in contrast to decreased uptake to the increased [EAAs] , that occur during many metabolic insults also remains unresolved.
EAAs are normally transported into neurons and glia against large concentration gradients by Na-EAA cotransporters, thereby maintaining low [EAAs] , (for discussion, see Erecinska, 1987) . These cotransporters utilize Na+ and K+ gradients to power the electrogenic uptake of glutamate (Glu), aspartate (Asp), and other EAAs across plasma membranes (Bouvier et al., 1992) . Na-EAA cotransporters are reversible (Erecinska and Dagani, 1990) and, therefore, alterations of Na+ and K+ gradients as well as membrane potential can affect the rate and direction of EAA transport (Szatkowski et al., 1990) . Decreased Na+ and K+ gradients occur during ATP depletion produced by hypoxia and hypoglycemia (see review by Hansen, 1985) . ATP depletion has been suggested to prevent the release of neurotransmitters. However, close examination of the issue suggests that although the Ca2+-dependent component of Glu release is decreased, the Ca2+-independent component is greatly increased by ATP depletion (Kauppinen et al., 1988) . Ca2+-independent release may be due to reversal of Na+ -dependent EAA uptake mechanisms. Dagani and Erecinska (1987; Erecinska and Dagani, 1990 ) have hypothesized, based on studies of synaptosomes, that ATP depletion produced by ischemia can inhibit Na/K-ATPases, resulting in ion gradient reductions and subsequent reversal of neuronal Na-EAA cotransporters.
The sites at which decreased uptake or increased release occurs merit investigation. Glu has several functions in the CNS (Fonnum, 1984) acting as an excitatory transmitter and as a major metabolic fuel in cultured astrocytes and, to a lesser extent, in some types of cultured neurons (Hertz et al., 1988) . Several lines of evidence suggest EAA metabolism is highly compartmentalized in the CNS. Studies employing labeled precursors ( Van den Berg, 1978) and immunocytochemical localization of EAAs (Ottersen et al., 1990) or enzymes involved in their synthesis and catabolism (Wenthold et al., 1986; Mad1 et al., 1988) suggest EAA metabolism differs greatly in glia and neurons and within subcellular compartments. Although ATP depletion has been shown to induce EAA release from synaptosomes, the relative contributions of glia and other regions of neurons to EAA release have not been reported in a system with intact architecture.
The relationships between inhibition of Na/K-ATPases, reversal of Na-EAA cotransporters, and increases in [EAAs] , during ATP depletion were therefore investigated in hippocampal slices, a model system with intact neuronal and glial compartments. Transport of D,L-threo-P-hydroxyaspartate (OH-Asp) was used to provide a novel, selective measure of cotransporter activity. Novel immunocytochemical studies of Glu redistribution Moderate ATP depletion was found to decrease EAA uptake without releasing EAAs. When ATP was further depleted by several different methods, EAA release was induced. Glu release was greatest from axonal terminal layers and occurred in a manner consistent with inhibition of Na/K-ATPases with subsequent reversal of Na-EAA cotransporters.
Materials and Methods
Slice preparation. Transverse, 400 pm sections of hippocampi were obtained from adult Sprague-Dawley rats essentially by the methods of Whittingham et al. (1984) . Slices were washed for 1 hr at room temperature (about 23°C) in Hank's balanced salt solution (1.25 mM CaCl,, 0.7 mM MgSO,, 5.4 mM KCl, 0.4 mM KH,PO,, 4.2 mM NaHCO,, 137 mM NaCl, 0.3 mM Na,HPO,, 5.6 mM glucose) containing an additional 10 mM glucose and 10 mM HEPES, pH 7.3, (HBSS) while being bubbled with 5% CO,, 95% 02. The pH of HBSS after equilibration with 5% CO? was 6.95, resembling mild tissue acidosis that occurs during ischemia. Decreasing pH did not significantly increase basal release of EAAs or release produced by ATP depletion unless pH was below 6.4 (J. E. Mad1 and K. Burgesser, unpublished observations) .
For uptake studies, slices were then loaded with 50 or 100 /IM D,Lthreo-fl-hydroxyaspartate (OH-Asp) in bubbled HBSS or in bubbled HBSS containing additional drugs for 1 hr at room temperature, rinsed in HBSS. homogenized in 0.5 ml of cold 0.3 N nerchloric acid. neutralized with 40-~1 of 3 M K,CO,, centrifuged to-remove precipitates, and used for determination of adenylates and amino acids. To increase the loading of OH-Asp and other transportable amino acids for studies of heteroexchange, loading was performed at 37°C.
For release studies, slices were loaded with OH-Asp as described for uptake studies, rinsed in HBSS, and incubated in experimental solutions for 1 hr in 0.5 ml or 4 ml of HBSS in a humidified incubator under room air with an additional 5% CO,, without bubbling, at 37°C. For studies involving EGTA chelation of Ca*+, CaCl, was replaced with 1 mM EGTA in the HBSS. Aliquots of supematants were collected and appropriately diluted in HBSS for amino acid analyses. Slices were then homogenized as before for HPLC determination of amino acids and adenylates. The amount of protein per slice was determined in the perchloric acid pellet using the Bio-Rad protein assay (Bio-Rad, Richmond, CA). Only small variations in slice size occurred from a mean of 145 PLg protein per slice; therefore, mean slice protein was assumed to be 145 PLg for most experiments.
Slices for immunocytochemical studies were treated as described for release studies, up to the point of homogenization, and then fixed for 1 hr with 4% paraformaldehyde and 0.3% glutaraldehyde in phosphatebuffered saline (PBS; pH 7.4).
HPLC determination of amino acids and adenylates. Amino acids were quantified in supematants and homogenates essentially by the method of Skilling et al. (1988) using a Rainin HPLC system with a Microsorb Cl8 column and guard column (Rainin Instrument Co., Wobum, MA) and a Spectrovision FD 100 fluorescence detector (Spectrovision, Chelmsford. MA). Modifications of the runnina conditions consisted'of minor changes in the gradient. Flow rate was kept constant at 0.5 ml/min, with initial conditions of 95% Na-acetate buffer (0.05 M, pH 6.05) and 5% methanol. Methanol was increased to 10% at 8 min, 20% at 12 min, 40% at 17 min, 48% at 22.5 min, and 90% at 29 min. OH-Asp was clearly separated from other amino acids under these conditions, with a short retention time of approximately 8.5 min. 1 -Aminocyclobutane-trans-1,3-dicarboxylic acid (ADC, Tocris Neuramin, Bristol, England) was also clearly separated from other amino acids with a retention time of approximately 18 min with this gradient.
Adenylates were determined essentially by the HPLC method of Stocchi et al. (1987) .
Immunocytochemical localization ofglutamate. Fixed slices were rinsed in PBS and incubated for 15 min in 3% H,O, to inactivate endogenous peroxidase. Artifacts due to the trauma of slicing are commonly present near the cut face ofthe transverse slices. To avoid these damaged regions near the edges of the slices, fixed slices were further sectioned by cutting 100 pm sections perpendicular to the long axis of the slices using a tissue chopper (see Fig. 1 ). Free-floating sections were incubated in 0.5 ml of 180,000 dilutions of Glu-2, a monoclonal antibody to glutaraldehydefixed glutamate, as previously described (McDonald et al., 1989) , in PBS containing 10 rg/ml of a conjugate of aspartate to bovine serum albumin prepared to decrease background staining. After incubation for 1.5 hr in primary antibody, sections were further processed using a Vectastain Elite Kit for mouse primary antibodies (Vector Laboratories, Burlingame, CA) essentially as described in McDonald et al. (1989) with diaminobenzidine as chromogen. Absorption controls were performed as previously described (McDonald et al., 1989) by preincubating the monoclonal antibody with 2 wg/ml of glutamate conjugated to bovine serum albumin. Sections were dehydrated in methanol, cleared in xylene, and mounted in Permount.
Density of Glu-like immunoreactivity. Density measurements were performed using an Olympus BH-2 microscope equipped with a Panasonic BD400 CCD and analyzed using NIH IMAGE 1.43 software. The light intensity of the microscope was set to give a mean density of less than 5 gray scale units in all strata of absorption controls. Density measurements were found to be linear up to 180 gray scale units using step wedges. Mean densities were obtained from 60 FrnZ areas from the center of the strata of sections to avoid artifacts near the cut edges. Densities of stratum oriens and stratum moleculare were taken approximately 10 pm from the neighboring cell body layer. Densities were taken from three representative slices from at least three different days' experiments for each treatment.
Line fittings and calculations ofcoefficients ofdetermination (R2) were obtained using CRICKET GRAPH 1.2 (Cricket Software, Malvem, PA). Analysis of variance was performed using STATWORKS (Heyden and Son, Philadelphia, PA). Newman-Kuels multiple comparison tests were performed using KWIKSTAT (TexaSoft, Cedar Hill, TX). Drugs and other materials were obtained from Sigma Chemical Co (St. Louis, MO) unless otherwise specified.
Results
To examine the relationship between ATP depletion and uptake, release, and metabolism of EAAs, inhibitors of diverse metabolic processes were used to reduce the ATP content of hippocampal slices. Effects of ATP depletion on EAA content of both supernatants and homogenates were measured to examine the release of EAAs and to determine whether Glu is catabolized in slices to generate ATP, which has been shown to occur in neuronal and glial cultures (Hertz et al., 1988) . To determine whether EAA release could be the result of altered cotransporter activity, uptake and release of OH-Asp, an EAA uptake inhibitor with high affinity for Na-EAA cotransporters (Anderson et al., 1990; Robinson et al., 199 l) , were measured.
The ATP content of control slices bubbled with 95% O,, 5% CO, in HBSS was 9.2 nmol/mg protein + 0.7 SEM, with an ATP:ADP ratio of 7.0 + 0.5 SEM and an energy charge (Atkinson, 1968) of 0.87 * 0.04 SEM. These results were similar to those reported by Whittingham et al. (1984) .
Moderate ATP depletion reduced EAA uptake Metabolic inhibition that depleted ATP to less than 8 nmol/mg protein decreased EAA uptake by Na-EAA cotransporters, measured by decreased slice uptake of OH-Asp. Moderate ATP depletion (8 2 ATP nmol/mg 2 3; see Table 1) Fixed, transverse hippocampal slices were sectioned perpendicular to the cut surface and perpendicular to the long axis of the slice as indicated using a tissue chopper. The resulting 100 Frn sections used for immunocytochemical localization of Glu contained strata of cells and processes as indicated in CA1 and the area dentata ofthe hippocampal formation. G, stratum granulare; M, stratum moleculare; P, stratum pyramidale; R, stratum radiatum.
of bubbling in OJCO, decreased uptake of OH-Asp by 80-90% without greatly increasing release of endogenous Glu (Fig. 2) . As seen in Figure 2 , similar decreases in uptake occurred when mild hypoxia due to lack of bubbling was combined with either the Krebs cycle inhibitor arsenite (Banks et al., 1976) or the electron transport inhibitor rotenone (Kauppinen and Nicholls, 1986) . Lack of a large release of endogenous Glu was evident by the retention of Glu in ATP-depleted slices. Release of Glu was not quantifiable in uptake studies involving loading of OHAsp due to the large amounts of OH-Asp (50-100 FM) present in the supematants. These large amounts of OH-Asp competed with Glu for derivitization with o-phthalaldehyde, which produced an artifactual lowering of quantities of amino acids (data not shown). Severe ATP depletion was probably prevented during these treatments by the greatly increased rate of glycolysis reported to occur with some metabolic inhibitors such as rotenone (Kauppinen and Nicholls, 1986) .
Severe ATP deletion released EAAs High doses of several metabolic inhibitors released endogenous EAAs as well as preloaded OH-Asp from slices ( Fig. 3) . Increased supematant concentrations of Glu with concomitant decreased homogenate concentrations were produced by either uncoupling oxidative phosphorylation with dinitrophenol, blocking electron transport with azide, or inhibiting glycolysis with iodoacetate (see Lehninger, 1975 , for a general description of metabolic inhibitors). The data shown were obtained by treatment of slices with the indicated metabolic inhibitor in combination with lowered oxygenation due to lack of bubbling. Treatment with high doses of iodoacetate decreased intracellular Glu more than could be accounted for by simple release (Fig.  3C ), suggesting that significant catabolism of Glu occurred during severe blockade of glycolysis. This catabolism of Glu was Table 1 for ATP levels produced by each treatment). EAA uptake was measured by the loading of OH-Asp into slices. Lack of release of EAAs was indicated by the high content of endogenous Glu retained in homogenates. Note the large decreases in uptake of OH-Asp that occurred when ATP was ~5 nmol/mg protein while endogenous Glu was largely retained in slices. Each point represents the mean of at least four samples after 1 hr treatment; error bars indicate SEM.
accompanied by increased Asp (Fig. 4A ) that may represent a conversion of Glu to Asp (Englesen and Fonnum, 1983; Sandburg et al., 1986) with increased release of both Glu and Asp (Fig. 4B ).
The release of Glu induced by different toxins (Fig. 5 ) was highly dependent on ATP content (R2 = 0.96 for an exponential curve fit). Different methods of ATP depletion were compared on the basis of percentage maximal release to compensate for Glu and Asp metabolism that occurred during iodoacetate treatment.
Both decreased uptake and increased release of EAAs were consistent with altered cotransporter activity It has been hypothesized, based on studies of synaptosomes, that ATP depletion could lead to release of EAAs by reversal of Na-EAA cotransporters. The results of several experiments were consistent with this hypothesis.
First, the effects of exogenous transportable EAA analogs on release were consistent with reversal of cotransporters. Uptake of EAA analogs by cotransporters will increase release of endogenous EAAs by the cotransporters, a process called heteroex- Figure 3C . Sup, supematants; Horn, homogenates.
change (Wilson and Pastusko, 1986; McMahon et al., 1989) . OH-Asp, ~-Asp, ADC, and L-truns-pyrrolidine-2,4-dicarboxylic acid (PDC; Tocris Neuramin, Bristol, England) are potent EAA uptake inhibitors (Bridges et al., 1991; Fletcher et al., 1991) . When large amounts of these analogs were preloaded into cells their effect was to increase the intracellular concentration of transportable molecules, leading to increased release of EAAs during ATP depletion. Figure 6A shows that increased total intracellular transportable amino acids due to preloading with OH-Asp led to increased release of total transportable amino acids (Asp, Glu, and OH-Asp) during ATP depletion. The amounts of Glu and Asp released were highly correlated with each other regardless of which transportable amino acid was loaded into slices (Fig. 6B) , consistent with the hypothesis that release of these transportable amino acids was due primarily to reversal of cotransporters. Different methods of ATP depletion induced a similar release of transportable amino acids. Increased supernatant contents of Glu, OH-Asp, and Asp were all highly correlated (R2 > 0.78) when release was induced by azide or dinitrophenol (Fig. 7) . Increases of supernatant Glu and Asp induced by iodoacetate were compared separately due to the changes in content of Glu and Asp induced by iodoacetate (Fig.   4A ).
The effects of administration of EAA uptake inhibitors during ATP depletion were complex. Treatment with the transportable EAA analog PDC during dinitrophenol-induced ATP depletion resulted in increased release of EAAs (Fig. f&4) , consistent with heteroexchange of EAAs with PDC. Treatment with nontransportable EAA uptake inhibitors during severe ATP depletion would be expected to block reversal of cotransporters and prevent EAA release. Surprisingly, two nontransportable EAA uptake inhibitors, dihydrokainate and arachidonic acid, were unable to prevent accumulations of [EAAs] , during severe ATP depletion (Fig. 8B) , possibly due in part to the low efficacy of dihydrokainate in some cell types (Barbour et al., 199 1) .
In contrast to release of EAAs, release of the nonexcitatory amino acids asparagine and glutamine was not dependent on ATP depletion (Fig. 9) . The lack of increased release of nonEAAs during ATP depletion suggests there was not a general increase in membrane permeability that would allow all amino acids to escape. Although a large release of nonexcitatory amino acids was obtained without ATP depletion, the retention of lo-20% of these amino acids in the slices suggests cells were still able to maintain large membrane gradients for these amino acids.
A second way in which release was consistent with reversal of Na-EAA cotransporters is that neither the release of endogenous EAAs nor OH-Asp could be significantly inhibited by chelation of extracellular Ca2+ with EGTA (Fig. lOA) . Inhibition of Na/K-ATPases has been hypothesized to reverse Na-EAA cotransporters by decreasing Na+ gradients used to power uptake of EAAs. If so, decreasing plasmalemmal Na+ gradients should result in release of EAAs similar to that produced by ATP depletion. Decreasing Na+ gradients with either veratridine or ouabain produced a release of EAAs that was not reduced by Ca*+ chelation with EGTA (Fig. lOB) , in a manner similar to the Ca*+-independent release produced by ATP depletion.
A final way in which release was consistent with reversal of Na-EAA cotransporters is the potentiation of the effects of ATP Total transportable amino acids represents the sum of OH-Asp, Asp, and Glu. R* = 0.87 for a logarithmic fit. OH-Asp was loaded at 6, 24, 100, and 400 PM for 1 hr at 37°C with bubbling in 95% 0,, 5% CO,.
B, Increases in the release of both Glu and Asp induced by different analogs were highly correlated. R2 = 0.9. Each point represents the mean of four replicate slices. ADC, 1 -aminocyclobutane-trans-1,3-dicarboxylic acid; PDC, L-truns-pyrrolidine-2,4-dicarboxylic acid. EAA analogs were loaded at 200 PM for 1 hr at 37°C with bubbling in 95% O,, 5% cop depletion by ouabain. If the ATP depletion-induced release of Glu and OH-Asp is due to inhibition of Na/K-ATPases, then the selective inhibitor of Na/K-ATPases, ouabain, should potentiate the effects of metabolic inhibitors. Treatment of slices with a combination of low doses of ouabain and metabolic inhibitors increased release in a highly synergistic manner, suggesting their mechanisms were not independent (Fig. 11A) . Moreover, if ATP depletion-induced release was the result of inhibition of Na/K-ATPases, then maximal inhibition of Na/ K-ATPases with ouabain should not be potentiated by ATP depletion. The release of Glu and OH-Asp produced by a high dose of ouabain was not significantly increased by azide or iodoacetate (Fig. 1 lB) , again consistent with the hypothesis that ATP depletion released EAAs by inhibition of Na/K-ATPases.
Sites of release during ATP depletion
To examine possible sites of release during ATP depletion, Glu was immunocytochemically localized in control and ATP-depleted slices. In agreement with previous immunocytochemical studies ( Storm-Mathisen et al., 1986; Ottersen et al., 1990) , much ofthe Glu-like immunoreactivity (GLIR) found in control slices allowed to recover their energy charge before fixation, was in punctate structures with morphology consistent with axonal terminals (Figs. 12A, 13A ). However, if slices were immediately fixed after slicing, large amounts of GLIR were found in neuronal perikarya and dendrites (Fig. 14) , similar to the distribution seen in perfusion-fixed tissue (Ottersen and Storm-Mathisen, 1984) . The amount of GLIR retained in CA1 pyramidal cell bodies and dendrites after incubation was somewhat variable from rat to rat. Usually perikarya of neurons farthest from the cut edge of the slice retained the most GLIR. Glu content of slices, measured by HPLC, did not change over the first hour while the apparent redistribution of GLIR from neuronal perikarya and dendrites to terminals occurred.
During severe ATP depletion, which released from one-third to two-thirds of the total Glu in the slices (Fig. 3) , GLIR was decreased in terminal-like structures ( Fig. 12B-D, 13C-E) . In contrast to the decreased GLIR in terminals, GLIR was increased in some cells with glial-like morphology (Fig. 13) . Also in contrast to terminals, GLIR in pyramidal cell perikarya was not greatly decreased during severe ATP depletion (Fig. 12B,C) . After moderate ATP depletion, which did not release substantial proportions of Glu from slices ( Fig. 2) , distribution of GLIR was not obviously different from control slices (Fig. 13B) . The marked decreases of GLIR in terminal-like structures during severe ATP depletion and less marked decrease in other structures suggest most of the Glu release occurred from terminals.
The relatively greater loss of GLIR from terminal-like structures was confirmed by measuring the mean densities of immunostaining in strata containing high proportions of terminals or cell bodies. As seen in Figure 154 , treatments that released about 40% (azide) or 70% (dinitrophenol) of the Glu from slices (Fig. 9 ) resulted in significantly decreased mean staining density of the slices. Analysis of different strata revealed a strong interaction between treatment and strata (p < 0.00 1 by ANOVA). When analyzed by multiple comparison tests, the predominant decreases of GLIR were seen in terminal-rich layers (Fig. 15B) , although a significant loss of GLIR was also seen in the granule cell layer during very severe ATP depletion (Fig. 15C) .
Treatments that decreased Na+ and K+ gradients produced redistributions of Glu similar to those seen during ATP depletion. Treatment of slices for 1 hr with either 60 mM K+ (Fig.  16A) , the Na+ channel opener veratridine (Fig. 16C) , or the Na/ K-ATPase inhibitor ouabain (Fig. 16B ) produced changes in GLIR distribution similar to those produced by ATP depletion, although increases in glial cell GLIR were even more pronounced than those seen with ATP depletion. Redistribution induced by both ATP depletion and reducing Na+ gradients included loss of GLIR from terminal-like structures, increased GLIR in cells with glial-like morphology, and retention of GLIR in pyramidal cell perikarya.
Discussion
Increased [EAAs] , are believed to mediate many neuronal insults. Although reversal of glial cotransporters induced by decreased Na+ and K+ gradients has been confirmed (Szatkowski et al., 1990) , little experimental evidence is available evaluating the role of ATP depletion in altering the activity of cotransporters. We therefore examined whether the increased [EAAs], occurring during metabolic insults were consistent with increased release and/or decreased uptake of EAAs mediated by a common mechanism such as ATP depletion.
One mechanism by which metabolic insults could release EAAs was selected for testing by several methods. This hypothesis proposes that increased [EAAs] , are due to reversal of Na-EAA cotransporters as a result of decreased Na+ and K+ gradients produced by inhibition of Na/K-ATPases (Dagani and Erecinska, 1987) . EAAs are normally transported into neurons and glia against a large concentration gradient by Na-EAA cotransporters, thereby maintaining low extracellular concentrations of Glu in the CNS (for discussion, see Erecinska, 1987) . The uptake of an amino acid is powered by cotransport of two Na+ into the cell and the release of a K+ and an alkalinizing anion into the extracellular fluid, resulting in a net influx of positive charge (Bouvier et al., 1992) . Na-EAA cotransporters are reversible and electrogenic; therefore, decreases of Na+ and K+ gradients as well as depolarization should first decrease the rate of uptake and eventually, if severe enough, reverse the net direction of EAA transport until a new equilibrium is reached based on the Nernst potentials for the ions and EAAs (Szatkowski et al., 1990; Bouvier et al., 1992) . Hypoxia and ischemia increase both intracellular Na+ concentrations and extracellular K+ concentrations (as reviewed by Hansen, 1985) , and should therefore reduce EAA uptake into cells. If these gradients are sufficiently decreased by severe metabolic insults, decreased EAA uptake should be followed by release of EAAs from cytosolic pools into the extracellular fluid by reversal of the cotransporters.
Is ATP depletion a common mediator of metabolic insult-induced (EAAsI, increases? Studies employing in vivo microdialysis suggest large accumulations of [EAAs] , occur during CNS insults that deplete ATP such as ischemia (Benveniste et al., 1984; Drejer et al., 1985) and hypoglycemia . In slices, severe ATP depletion induced by either inhibition of glycolysis, inhibition of electron transport, or uncoupling of oxidative phosphorylation all led to greatly increased supernatant EAAs with reductions of intracellular EAAs, consistent with an increased release of EAAs. The strong correlation between ATP depletion and release of EAAs is consistent with ATP depletion mediating the bulk of the EAA release produced by these different metabolic insults. However, blockade of glycolysis also led to an apparent conversion of Glu to Asp, suggesting that certain metabolic insults can also lead to significant metabolism of EAAs, thus affecting the quantities of EAAs available for release.
Are increased [EAAs] , the result of nonselectively increased membrane permeability, altered cotransporter activity, or increased vesicular release? It is unlikely that the majority of the release of EAAs observed during ATP depletion was the result of nonselective increases of membrane permeability for several reasons. First, in contrast to EAAs, release of the non-EAAs glutamine and asparagine did not depend on ATP depletion, suggesting ATP depletion did not produce "leaky" membranes. Second, only about half of the total Glu was released during severe ATP depletion, suggesting membranes could still maintain large EAA gradients. The large amounts of GLIR remaining in pyramidal cell perikarya of ATPdepleted slices (Fig. 12 ) also suggest there was no major loss of plasmalemmal integrity.
The bulk of the release of EAAs was consistent with reversal of Na-EAA cotransporters in several ways. First, the amounts of Glu and Asp released were highly correlated with each other and with the release of preloaded transportable EAA analogs. Second, heteroexchange with other transportable amino acids increased the ATP depletion-induced release of EAAs. Bouvier et al. (1992) suggested the extracellular concentration of Glu at equilibrium should depend on the Nernst potential for Glu. Increasing intracellular Glu or preloading large amounts of any transportable amino acid should then increase the release of all transportable amino acids to reach the same final ratio of [EAAs],:
[EAAs],. Third, release produced by reversing Na-EAA cotransporters through decreasing Nat and K+ gradients resembled the release produced by ATP depletion in both Ca2+ insensitivity (Fig. lo) , and selective loss of Glu from terminal regions (Fig.  15) . Fourth, as discussed in a following section, ATP depletion and ouabain act synergistically to increase EAA release, suggesting both act by decreasing Na+ and K+ gradients. Finally, inhibition of EAA uptake occurred before release of EAAs. This is consistent with milder ion gradient changes inhibiting cotransporter uptake, followed by reversal of uptake and release of EAAs by more severe changes.
It is unlikely exocytosis from synaptic vesicles contributed substantially to release for several reasons. First, Asp is not loaded into synaptic vesicles, nor is it likely that OH-Asp is Figure 12 . Effects of ATP depletion and Na+ influx on GLIR in CAl. A, Section of unbubbled slice showing intense staining for Glu in puncta with terminal-like morphology in stratum radiatum (R) and stratum oriens (0). Note staining of some pyramidal cell bodies (arrowheads). B, Effects of azide (5 mM) on Glu distribution. Reduced intensity of staining of puncta in stratum radiatum and stratum oriens was evident, with staining retained or increased in pyramidal cell perikarya (arrowheads). C, Effects of dinitrophenol (2 mM) on Glu distribution. Note reduced staining of nuncta and retention of Dvramidal cell staining (arrowheads). D. Effects of increasing Na+ influx with veratridine (50 WM) on Glu distrib;tion: Note similarities of Glu-redistribution to ATP-depletion shown in B and C. IncreasedNa+ influx and ATP depletion' both decreased intensity of punctal staining in stratum radiatum and stratum oriens with retention of Glu in pyramidal cell perikarya (arrowheads). All parts of the figure have similar orientation and the same magnification. P, stratum pyramidale. Scale bar, 50 Wm.
loaded into synaptic vesicles, given the specificity of vesicular loading mechanisms (Naito and Ueda, 1985) . Second, the inability of chelation of extracellular Ca*+ with EGTA to block release of EAAs also suggests the release occurred primarily by a nonexocytotic mechanism, consistent with reversal of Na-EAA cotransporters. Finally, Ca*+-dependent release occurs chiefly during the first 5 min ofischemia (Katayama et al., 199 1) or exposure to high concentrations of K+ (Kish and Ueda, 199 1; reviewed by Adam-Visi, 1992) suggesting the release obtained over 1 hr of ATP depletion has only a small component due to vesicular release.
Are the increases of [EAAsj, due to both decreased uptake and increased release of EAAs, and does either means of increasing [EAAsj, predominate during milder insults? Moderate ATP depletion, such as that produced by lack of bubbling of slices with oxygen, reduced uptake of EAAs to lo-20% of bubbled slices with little release of endogenous EAAs. These results are similar to those of Pastuszko et al. (1982) who found that anoxic incubations of synaptosomes decreased uptake without increasing release of GABA or other transmitters. The mild ATP depletion produced early in hypoxia/ischemia may produce an inhibition of uptake of EAAs from the synaptic cleft, contributing to neuronal depolarization and interruption of synaptic transmission that occurs in hypoxic slices Whittingham, 1979, 1982) . Increased excitation of cat spinal motor neurons by EAAs occurs when EAA uptake is inhibited with OH-Asp, suggesting synaptic transmission can be rapidly altered by lack of uptake of EAAs (Johnson et al., 1980) . Rosen and Morris (199 1) have suggested that a release of EAAs due to partial failure of Na/K-ATPases may contribute to anoxic depolarization of rat neocortical slices. In addition to any rapid effects on synaptic function, decreased EAA uptake might also contribute to neuronal damage. Neuronal damage consistent with excess EAA stimulation was seen after injection of OHAsp in rat striatum, suggesting lack of uptake of EAAs released during normal processes may be sufficient to produce excitotoxic neuronal damage (McBean and Roberts, 1985) . The prolonged activation of postsynaptic cells by inhibition of EAA uptake may contribute to the neuronal depolarization seen during hypoxia of the CNS and may contribute to hypoxic/ischemic neuronal damage.
It should be noted that the ATP content of even bubbled slices is only about half that of in vivo CNS tissue. This suggests that even highly oxygenated control slices may already exhibit some differences from normal tissue. However, as discussed by Whittingham et al. (1984) the energy charge of slices approaches that of in viva tissue (about 0.9). These seemingly contradictory results are consistent with a large release of adenosine and other adenylates during the process of making slices, when the energy charge of the slice is lowered to about 0.4. A similar release of adenosine and accumulation of its metabolites hypoxanthine and inosine has been reported during in vivo ischemia . These adenylates may then be unavailable for t The Journal of Neuroscience, October 1993, 73(10) 4439 reuptake due to dilution or changing rinse solutions even after slices have recovered from the process of slicing. We have observed the release of large amounts of adenosine, hypoxanthine, and inosine into washing media during slice preparation that could result in lowered adenylates after recovery (data not shown).
Are changes in cotransporter activity mediated by inhibition of Na/K-ATPases during ATP depletion? Much of the ATP generated in the CNS is used to power Na/ K-ATPases that maintain Na+ and K+ gradients (Erecinska and Dagani, 1990) . Na/K-ATPases have a low-affinity binding site for ATP (approximate K,,, = 0.2-0.4 mM; Glynn and Karlish, 1975; Robinson, 1982) that.may regulate their activities. It has been suggested by Dagani and Erecinska (1987) and Kauppinen et al. (1988) that depletion of ATP during pathologic processes could lead to inhibition of Na/K-ATPases, resulting in decreased Na+ and K+ gradients and a reversal of Na-EAA COtransporters. The release of Glu from synaptosomes they observed during ATP depletion was consistent with decreases in ion gradients and Na/K-ATPase activity. The dependence of release on ATP concentration is consistent with the hypothesis that reversal of the cotransporters during ATP depletion is due to a single mechanism such as inhibition of the Na/K-ATPases.
The release produced by decreasing Nat or K+ gradients resembled that produced by ATP depletion. Both produced primarily a Caz+-insensitive release of EAAs (Fig. lo) , and both caused a redistribution of Glu similar to those produced by ouabain and ATP depletion (Fig. 16) .
To test more directly whether inhibition of the Na/K-ATPase mediates ATP depletion-induced release of EAAs, the effects of ATP depletion on ouabain-induced release were examined. Ouabain, a selective inhibitor of Na/K-ATPases (Sweadner, 1989) may release EAAs by reversing Na-EAA cotransporters as a result of decreased plasma membrane Na+ and K+ gradients. Ouabain-induced release was similar to ATP depletioninduced release both in Ca2+ insensitivity (Fig. 10B ) and in the changes in Glu distribution they produce (Fig. 16) . Ouabain does not reduce slice ATP content sufficiently to produce depletion-dependent release of EAAs (data not shown). Treatment of slices with a combination of low doses of ouabain and toxins resulted in highly synergistic release of EAAs (Fig. 1 lA) , suggesting the release was not independent. A combination of high doses of ouabain with either azide or iodoacetate produced a release that was not significantly increased above that achieved by ouabain alone (Fig. 11B) . The inability of ATP depletion to increase ouabain-induced release strongly suggests the release of EAAs due to ATP depletion was mediated by inhibition of Na/K-ATPases. Does release of Glu occur selectively from glia, neurons, or subcellular locations such as nerve terminals? Immunocytochemical localization of Glu in slices allowed to recover their energy charge suggests large amounts of Glu are found in axonal terminals (Storm-Mathisen et al., 1986) . Severe Figure  13 . Effects of ATP depletion on GLIR in the area dentata. A, Control section showing intense staining for Glu in terminal-like punctate structures in stratum moleculare (M). Note lack of staining of granule cells in stratum granulosum (G). B, Lack of effect of moderate ATP depletion with rotenone on Glu distribution. Note intense staining of puncta in stratum moleculare is retained. C, Effects of severe ATP depletion with dinitrophenol (2 mM) on Glu distribution. Note reduced intensity of staining of puncta in stratum moleculare. Some intense labeling of glial-like cells is evident (arrowheads). D, Effects of severe ATP depletion with iodoacetate (2 mM) on Glu distribution. Note reduced intensity of staining of puncta in stratum moleculare. E, Effects of severe ATP depletion with azide (5 mM) on Glu distribution. Note reduced intensity of staining of puncta in stratum moleculare. All parts of the figure have similar orientation and the same magnification. Scale bar, 50 pm.
ATP depletion released more than half the Glu in slices (Fig.  9 ) and decreased GLIR in these terminal-like structures, suggesting release of EAAs occurred primarily from axonal terminals. These results are consistent with reports that deafferentation decreased release of EAAs produced by hypoglycemia and ischemia (Benveniste et al., 1989) , suggesting the primary site of release was from terminals. It is unlikely glia contributed greatly to the increased release seen during ATP depletion. In contrast to terminals, cells with gliallike morphology infrequently contained large amounts of GLIR in control slices. ATP depletion increased the number of intensely labeled cells with glial-like morphology, suggesting Glu may accumulate in some glia during ATP depletion, rather than be released. HPLC data indicate severe ATP depletion released large proportions of the Glu in slices. Taken together with immunocytochemical studies suggesting GLIR is decreased primarily from terminals during ATP depletion, these results strongly suggest most of the release during ATP depletion is from terminals. Glu within the cytosolic compartment of these terminals, rather than Glu in synaptic vesicles, is the most likely source of the released Glu since the cytosolic pool is accessible to the Na-EAA cotransporters associated with the plasmalemma. Lack of a major contribution of exocytosis to ATP depletion-induced release is also suggested by the inability of EGTA to decrease release.
Several reasonable mechanisms could account for the differential loss of EAAs from neuronal cell bodies, axonal terminals, and glia. Likely mechanisms include the nonhomogeneous distributions of cotransporters or subunits of Na/K-ATPases.
Immunocytochemical localization of subunit isoforms in the hippocampus indicated pyramidal cell bodies possess large amounts of the ot3 isoform with some (~1 labeling, while pyramidal cell dendrites appeared to possess primarily o( 1. Stratum oriens was highly labeled for c~2 and a3, while stratum radiatum was labeled for all three isoforms, suggesting terminals may contain large amounts of the 012 and ot3 isoforms (McGrail et al., 199 1) . The al isoform has a threefold lower K,,, for Na+ and a slightly lower K,,, for ATP (Jewel1 and Lingrel, 199 1) . Differences in the K,,, of these isoforms for both Na+ and ATP might result in different Na+ and K+ gradients, producing regional differences in neuronal uptake and release of EAAs by cotransporters. The higher Km for Na+ of ot3 pumps of neurons suggests higher levels of intracellular Na+ may accumulate in neurons or within regions of the neurons such as axonal terminals, perhaps leading to easier reversal of cotransporters in these regions during ATP depletion. It is also likely that cotransporters are not homogeneously distributed throughout neurons and glia. Wiklund et al. (1984) reported that ~-Asp is selectively taken up by axonal terminals and glia in the cerebellum and not by neuronal perikarya. This indication that neuronal EAA uptake sites occurs primarily on terminals is consistent with our findings that release of EAAs due to reversal of the cotransporters may also occur principally at terminals. Another mechanism that could account for a relatively greater release of Glu from terminals concerns the smaller size of ter- insult by dinitrophenol significantly decreased staining densities ofgranule cell layers. In contrast, a less severe insult by azide was unable to produce significant decreases in immunoreactivity of either the pyramidal cell or granule cell layers. *, p < 0.05 from control by NewmanKuels multiple comparison test. In B and C each column represents the mean staining density of four sections taken from three separate immunocytochemical experiments processed on different days; error bars indicate SEM. DNP, dinitrophenol; M, stratum moleculare; 0, stratum oriens: G, stratum granulare; P, stratum pyramidale. intensely stained for Glu. Puncta in stratum radiatum (R) and stratum oriens (0) have not yet acquired intense labeling compared with surrounding structures. B, Many granule cells of the area dentata are intensely labeled (arrowheads). Puncta in the stratum moleculare (M) have not yet acquired intense labeling compared to surrounding structures. C, Absorption control showing lack of staining of CA1 when the monoclonal antibody to glutaraldehyde-fixed Glu is preincubated with Glu conjugated to bovine serum albumin. P, stratum pyramidale. Scale bars, 25 pm. (Fig. 15) .
